Freeze Dried Protein Epidermal Growth Factor Egf For Skin Cosmetics 1Ng / ML ED50

Freeze Dried Protein Epidermal Growth Factor Egf For Skin Cosmetics 1Ng / ML ED50​

Description

rhEGF can promote the cell mitosis and extracellular matrix synthesis and accelerate the start of wound tissue regeneration, repair and shorten the wound healing time. In addition, it can regulate the degradation and renewal of collagen, make the collagen fibers arranged in a linear way, enhance the tensile strength of the wound, reduce the scar formation and improve the quality of healing.

Quick detail

1. CAS No.: 62253-63-8
2. Place of Origin: Wuhan, China (Mainland)
3. Brand Name: Oryzogen
4. Model Number: HYC020M01
5. Purity: Greater than 98 % as determined by SDS-PAGE
6. Physical Appearance: white lyophilized powder
7. Formulation: hrEGF is lyophilized with mannitol as the stabilizer
8. Endotoxin: Less than 1.0 EU/mg

Advantages

1. The chairman of Healthgen Biotech Professor Daichang.Yang is one of China's chief scientists. Professor Yang has rechieved the “Thousand Talents program” of the National Central Organization Department, "Hundred Talents Program" of the Organization Department of Hubei Province and Top 10 "Venture Eagle" entrepreneurs.

2. With years of effort, Healthgen Biotech has developed the State-of-the-Art platform called Oryz^HiExp, having high capacity to express no animal origin proteins and peptides in the rice endosperm cells.

3. The lyophilized powder rhEGF can keep the stability and bioactivity. The lyophilized powder effectively prevents the changes of physical, chemical properties and biological characteristics of rhEGF. It has small damage to biological structure and characteristics of the dormant state and can make them quickly enter the sleep state. So the EGF freeze-dried powder can be stored at -20 ℃ for more than 24 months. The appearance of our EGF powder is white color, which is the same as the EGF derived from E.coli. 

Supplemental Description 

Healthgen Biotech, always pay great attention to the original technological innovation and intellectual property protection, has the titles of “Hubei Province Molecular Pharmaceutical Engineering Research Center” and “Protein Purification Research Center”. The rice endosperm cell high expression technology platform and other core technology have applied and gained 13 domestic and international patents; and won the “2012 Hubei Provincial Science and technology invention Award”, “2013 National Science and Technology Invention Award and China Patent Excellence Award’. The project obtained the funding from the National Ministry of science and high technology “863 plan”, Major national science and technology plan “Major projects of new varieties of genetically modified organisms” and “Major projects for new drug discovery”, the National Development and Reform Commission “Pilot development of strategic emerging industries”, National Ministry of science and technology innovation fund and state and local plans for all kinds of talented people funding. In July 2015, Healthgen Biotech became a public company on the "China New OTCBB", a national share transfer system for SMEs and officially known as the National Equities Exchange and Quotations, which is the “first stock” of the plant-derived pharmaceutical in China and even the world.